Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EHR “Meaningful Use” Requirements Raise Expectations For Health Information Exchange In Stage 2

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS highlights the greater role that health information exchange will play in stage 2 meaningful use for electronic health records and sets the stage for an even more robust use of health data to promote safety and efficiency as the agency moves toward stage 3.

You may also be interested in...

Payment Reform Is Among The Keys To Unlocking Health IT Potential – RAND Commentary

Adoption of electronic health records continues to rise, but analysis from the RAND Corp. suggests that interoperability and technical issues continue to keep the promise of lower cost and higher quality health care at bay, with a key factor in changing that course being a move to a health care delivery system that favors paying for value rather than quantity.

As EHR Use Grows, Physicians’ View Of Their Impact Is Moderating

The adoption and meaningful use of electronic health records may have surpassed goals set by the HHS, but a survey of physicians suggests the high expectations for the benefits of EHRs on patient care are coming down, at least among health care providers.

EHRs Become A Stronger Research Tool Under Proposed Stage 2 Meaningful Use Rule

Use of electronic health records to report data to disease registries, for both cancer and non-cancer conditions, becomes an optional objective for providers to demonstrate “meaningful use” of EHRs under CMS’ proposed stage 2 requirements. An objective to identify patients for potential research opportunities also carries over to the stage 2 proposal.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts